Results 31 to 40 of about 1,939 (155)

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA

Emerging Infectious Diseases, 2023
We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat.
Maura K. Lash, Ned H. Latham, Pui Ying Chan, Mary M.K. Foote, Elizabeth A. Garcia, Matthew F. Silverstein, Marcia Wong, Mark Alexander, Karen A. Alroy, Lovedeep Bajaj, Kuan Chen, James Steele Howard, Lucretia E. Jones, Ellen H. Lee, Julian L. Watkins, Tristan D. McPherson   +15 more
doaj   +1 more source

Battle won, war ongoing: A call for mpox vaccination in high-risk dermatologic cases [PDF]

JAAD Case Reports
Atika Malik, MD, Monique Kumar, MD, Tien-Anh N. Tran, MD, Timmy Do, PharmD, BCPS, BCIDP, Lindsay Lim, MD, DTMH   +4 more
doaj   +2 more sources

Efficacy of three key antiviral drugs used to treat orthopoxvirus infections: a systematic review

Global Biosecurity, 2019
Background: In a global political climate increasingly concerned about terrorism, bioterrorism agents such as smallpox would undoubtedly be catastrophic.
Joyce Yu, Suresh Mahendra Raj
doaj   +1 more source

Monkeypox - new epidemiological threat? Review of the current literature

Journal of Education, Health and Sport, 2023
The mokeypox is zoonotic disease caused by an orthopoxvirus, which was first isolated and identified in 1959 among captive monkeys transported to Copenhagen, Denmark from Africa for research purposes.
Dominika Jarosz, Aleksandra Grudzińska, Paulina Dudzińska, Małgorzata Milanowska, Hanna Tsitko   +4 more
doaj   +1 more source

Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks

Health Science Reports, 2022
Background and aims There is a sought for vaccines and antiviral agents as countermeasures for the recent monkeypox outbreak. Here, we aimed to review and discuss the repurposing potentials of smallpox vaccines and drugs in monkeypox outbreaks based on ...
Md. Rabiul Islam, Md. Jamal Hossain, Arpita Roy, A. H. M. Nazmul Hasan, Md. Ashrafur Rahman, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan   +6 more
doaj   +1 more source

Monkeypox - review

Journal of Education, Health and Sport, 2022
Introduction and purpose:  This review aims to analyze the current information about monkeypox and the virus which causes the disease.  Material and method: This review was based on articles collected in PubMed and published in the years 2012-2022
Aleksandra Amalia Kuchnicka, Katarzyna Kosz, Julia Kuchnicka, Klaudia Remjasz, Natalia Zarankiewicz, Martyna Zielińska, Klaudia Sapuła, Jakub Aleksandrowicz, Wojciech Siedlecki   +8 more
doaj   +1 more source

Toxicological Potential of the FDA-Approved Treatment against Monkeypox. Comment on Zovi et al. Pharmacological Agents with Antiviral Activity against Monkeypox Infection. Int. J. Mol. Sci. 2022, 23, 15941

International Journal of Translational Medicine, 2023
Recently, some drugs were approved to control Monkeypox (MPX), among them tecovirimat. This was recently approved by regulatory agencies around the world, the paper of Zovi et al entitled Pharmacological Agents with Antiviral Activity against Monkeypox ...
Gabriel Christian de Farias Morais, Umberto Laino Fulco, Edilson Dantas da Silva, Claudio Bruno Silva de Oliveira, Jonas Ivan Nobre Oliveira   +4 more
doaj   +1 more source

Short Note on Tecovirimat

Journal of Pharmaceutical Research International, 2021
Smallpox, an infectious disease, caused by one of the two virus variants, Variola major and Variola minor. Smallpox is a highly contagious and fatal disease. The last case which occurred naturally was in October 1977. The disease was eradicated globally by the World Health Organisation in the year 1980.
C. Sushil, S. Padmaja
openaire   +2 more sources

Case report: From monkeypox pharyngitis to myopericarditis and atypical skin lesions

Frontiers in Cardiovascular Medicine, 2023
BackgroundA global outbreak of the human monkeypox virus (HMPXV), first identified in May 2022, was declared a health emergency of international concern on 23 July 2022. Before the global outbreak, monkeypox cases were mostly confined to central and west
María Ascensión Sanromán Guerrero, Elena Hernández Sánchez, Belén de Nicolás Ruanes, Pablo Fernández-González, Sonia Antoñana Ugalde, Alejandra González Leal, Marcelo Sanmartín Fernández, Jose Javier Alarcón Rodríguez, Laura Martinez Garcia, Rosa Escudero, Maria Ángeles Fernández Méndez, Jose Luis Zamorano Gómez, Beatriz Montero Llorente, Maria Jesús Vivancos-Gallego   +13 more
doaj   +1 more source

Monkeypox in human pregnancy: an overview

AJOG Global Reports, 2022
Monkeypox is a viral zoonosis caused by the monkeypox virus, an enveloped, double-stranded DNA virus belonging to the Orthopoxvirus genus in the Poxviridae family. Monkeypox has become a disease of global public health significance.
Sulaiman Muhammad Daneji, MBBS, FWACS, Aliyu Aminu, MBBS, FMCPath, Awwal Musa Borodo, MBBS, MSc, FWACP, FMCPath, Farouq Muhammad Dayyab, MBBS, MPH, FMCP   +3 more
doaj   +1 more source